Autologous serum therapy for chronic urticaria :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Autologous serum therapy is more effective than antihistamine to treat chronic urticaria

Chronic Urticaria Chronic Urticaria
Chronic Urticaria Chronic Urticaria

What's new?

For the management of chronic urticaria, autologous serum therapy is superior to antihistamine.

Autologous serum therapy is more efficient than antihistamine in managing chronic urticaria, according to a randomized controlled clinical study. In order to treat chronic urticaria, researchers compared the effectiveness of intramuscular platelet rich plasma with an oral antihistamine.

Overall, 100 subjects were incorporated and randomly allocated to group A (n=50) and group B (n=50). Patients in group A received 9 intramuscular autologous serum injections, whereas subjects in group B were administered oral antihistamines routinely. Both treatment options' efficacy was evaluated using the Urticaria Activity Score-7 (UAS-7) scale.

The UAS-7 in the autologous serum group and the antihistamine group at baseline, 4th week, 9th week, and 12th week is depicted in Table 1:

Thus, autologous serum therapy is more effective as compared to an antihistamine to relieve chronic urticaria.

Source:

Pakistan Journal of Medical & Health Sciences

Article:

Efficacy of Intramuscular Platelet Rich Plasma Versus Oral Antihistamine In Chronic Urticaria

Authors:

Naseemullah AQ et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: